Anticholinergics in asthma: are we utilizing asthma therapies effectively?
Christian Vogelberg Department of Pediatric Pulmonology and Allergy, University Hospital Carl Gustav Carus, Technical University of Dresden, Dresden, GermanyData have shown that asthma is the most prevalent chronic respiratory disease, affecting 358 million people worldwide in 2015.1 While...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-03-01
|
Series: | Therapeutics and Clinical Risk Management |
Subjects: | |
Online Access: | https://www.dovepress.com/anticholinergics-in-asthma-are-we-utilizing-asthma-therapies-effective-peer-reviewed-article-TCRM |
_version_ | 1819141061225742336 |
---|---|
author | Vogelberg C |
author_facet | Vogelberg C |
author_sort | Vogelberg C |
collection | DOAJ |
description | Christian Vogelberg Department of Pediatric Pulmonology and Allergy, University Hospital Carl Gustav Carus, Technical University of Dresden, Dresden, GermanyData have shown that asthma is the most prevalent chronic respiratory disease, affecting 358 million people worldwide in 2015.1 While data show that the age-standardized asthma-related death rate decreased by 58.8% from 1990–2015,1 asthma still represents a significant burden in terms of morbidity.2 As such, there is an important role for utilizing add-on therapy options. The focus of this review series is on the use of long-acting anticholinergic add-on therapy to reduce asthma morbidity. |
first_indexed | 2024-12-22T11:48:27Z |
format | Article |
id | doaj.art-c725bb8fd2dd486994b01207ae4cca9a |
institution | Directory Open Access Journal |
issn | 1178-203X |
language | English |
last_indexed | 2024-12-22T11:48:27Z |
publishDate | 2019-03-01 |
publisher | Dove Medical Press |
record_format | Article |
series | Therapeutics and Clinical Risk Management |
spelling | doaj.art-c725bb8fd2dd486994b01207ae4cca9a2022-12-21T18:27:05ZengDove Medical PressTherapeutics and Clinical Risk Management1178-203X2019-03-01Volume 1540540844584Anticholinergics in asthma: are we utilizing asthma therapies effectively?Vogelberg CChristian Vogelberg Department of Pediatric Pulmonology and Allergy, University Hospital Carl Gustav Carus, Technical University of Dresden, Dresden, GermanyData have shown that asthma is the most prevalent chronic respiratory disease, affecting 358 million people worldwide in 2015.1 While data show that the age-standardized asthma-related death rate decreased by 58.8% from 1990–2015,1 asthma still represents a significant burden in terms of morbidity.2 As such, there is an important role for utilizing add-on therapy options. The focus of this review series is on the use of long-acting anticholinergic add-on therapy to reduce asthma morbidity.https://www.dovepress.com/anticholinergics-in-asthma-are-we-utilizing-asthma-therapies-effective-peer-reviewed-article-TCRMasthmaanticholinergictiotropiumadultchildrenpreschool childreninhaler |
spellingShingle | Vogelberg C Anticholinergics in asthma: are we utilizing asthma therapies effectively? Therapeutics and Clinical Risk Management asthma anticholinergic tiotropium adult children preschool children inhaler |
title | Anticholinergics in asthma: are we utilizing asthma therapies effectively? |
title_full | Anticholinergics in asthma: are we utilizing asthma therapies effectively? |
title_fullStr | Anticholinergics in asthma: are we utilizing asthma therapies effectively? |
title_full_unstemmed | Anticholinergics in asthma: are we utilizing asthma therapies effectively? |
title_short | Anticholinergics in asthma: are we utilizing asthma therapies effectively? |
title_sort | anticholinergics in asthma are we utilizing asthma therapies effectively |
topic | asthma anticholinergic tiotropium adult children preschool children inhaler |
url | https://www.dovepress.com/anticholinergics-in-asthma-are-we-utilizing-asthma-therapies-effective-peer-reviewed-article-TCRM |
work_keys_str_mv | AT vogelbergc anticholinergicsinasthmaareweutilizingasthmatherapieseffectively |